SCHEMBL1881322

SCHEMBL1881322

CCCC(O)CCCCCCCC(=O)O

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 3/20 0.85
▸ FFAR1 O14842 3/20 0.85
▸ ALDH1A1 P00352 3/20 0.63
▸ GPR84 Q9NQS5 7/20 0.58
▸ PPARG P37231 6/20 0.58
▸ PPARD Q03181 6/20 0.58
▸ PPARA Q07869 6/20 0.58
▸ HDAC11 Q96DB2 5/20 0.58
▸ TSHR P16473 4/20 0.58
▸ TLR2 O60603 2/20 0.58
▸ TDP1 Q9NUW8 2/20 0.58
▸ FABP4 P15090 2/20 0.58
▸ PTPN1 P18031 2/20 0.58
▸ SLC22A6 Q4U2R8 1/20 0.58
▸ SLC22A8 Q8TCC7 1/20 0.58
▸ MEN1 O00255 1/20 0.58
▸ ESR1 P03372 1/20 0.58
▸ ALOX15 P16050 1/20 0.58
▸ PDE4A P27815 1/20 0.58
▸ KMT2A Q03164 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31524795 1.00 FFAR4 (0.85) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL1301396 1.00 FFAR4 (0.85) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL31524916 1.00 FFAR4 (0.85) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL31524960 1.00 FFAR4 (0.85) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL1884346 1.00 FFAR4 (0.85) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL1881604 1.00 FFAR4 (0.85) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL335502 1.00 FFAR4 (0.85) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL16230497 1.00 FFAR4 (0.85) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL31524686 1.00 FFAR4 (0.85) FFAR4FFAR1ALDH1A1GPR84PPARG
SCHEMBL31524893 1.00 FFAR4 (0.85) FFAR4FFAR1ALDH1A1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595495-B2 Methods of producing omega-hydroxylated fatty acid derivatives GENOMATICA, INC. (US) 2026-04-07 — — US disclosed
US-12522686-B2 Method for producing hydroxy-fatty-acid-based polyols U. WINDMÖLLER INNOVATION GMBH & CO. KG (DE) 2026-01-13 — — US disclosed
CN-113293150-B Mutant enzymes 牛津大学科技创新有限公司 2025-05-13 — — CN disclosed
EP-4150103-B1 METHOD FOR MANUFACTURING HYDROXY FATTY ACID-BASED POLYOLS U WINDMOELLER INNOVATION GMBH & CO KG (DE) 2025-04-09 — — EP disclosed
US-20250019731-A1 Methods Of Producing Omega-Hydroxylated Fatty Acid Derivatives AGAIN BIO APS (DK) 2025-01-16 — — US disclosed
CN-118460487-A Process for producing OMEGA-hydroxylated fatty acid derivatives 基因组股份公司 2024-08-09 — — CN disclosed
CN-118374462-A Process for producing OMEGA-hydroxylated fatty acid derivatives 基因组股份公司 2024-07-23 — — CN disclosed
US-11981952-B2 Methods of producing omega-hydroxylated fatty acid derivatives GENOMATICA, INC. (US) 2024-05-14 — — US disclosed
CN-105378486-B Process for producing OMEGA-hydroxylated fatty acid derivatives 基因组股份公司 2024-05-14 — — CN disclosed
US-20230312805-A1 METHOD FOR PRODUCING HYDROXY-FATTY-ACID-BASED POLYOLS UNIVERSITÄT BIELEFELD (DE) 2023-10-05 — — US disclosed
WO-2009158633-A1 DRUG CONJUGATES CURATORS OF THE UNIVERSITY OF MISSOURI ON BEHALF OF THE UNIVERSITY OF MISSOURI-KANSAS CITY (US) 2009-12-30 — — WO disclosed
WO-2009047498-A2 MUTANT ENZYMES ISIS INNOVATION LIMITED (GB) 2009-04-16 — — WO disclosed
CN-100387705-C Anti-fouling compounds and methods for producing the same UNIV HONG KONG SCIENCE & TECHN (HK) 2008-05-14 — — CN disclosed
US-7090856-B2 Anti-fouling exopolysaccharides isolated from cultures of Vibrio alginolyticus and Vibrio proteolyticus HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (HK) 2006-08-15 — — US disclosed
CN-1572867-A Anti-fouling compounds and methods for producing the same UNIV HONG KONG SCIENCE & TECHN (HK) 2005-02-02 — — CN disclosed
EP-0808625-B1 External skin-care composition KAO CORP (JP) 2002-08-07 — — EP disclosed
EP-1021551-A1 PLANT FATTY ACID HYDROXYLASE GENES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2000-07-26 — — EP disclosed
WO-1999018224-A1 PLANT FATTY ACID HYDROXYLASE GENES THE CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE (US) 1999-04-15 — — WO disclosed
US-5783601-A CONTAINING HYDROXYCARBOXYLIC ACIDS KAO CORPORATION (JP) 1998-07-21 — — US disclosed
EP-0808625-A1 External skin-care composition Kao Corporation (JP) 1997-11-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595495-B2 Methods of producing omega-hydroxylated fatty acid derivatives CYP4F11, CYP2F1, CYP4Z1 FFAR4 95/4885FFAR1 112/4885ALDH1A1 327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback